Which immunotherapy companies will be around in 2028?
8
498Ṁ159
2028
62%
Wyndly
60%
Curex
59%
Nectar

I'm trying to pick a provider for at-home sublingual immunotherapy (SLIT), but it takes up to four years to finish and I'm worrying about a startup going out of business or being acquired and no longer offering immunotherapy.

Curex:

  • founded 2020

  • can't find funding info

Wyndly:

  • founded 2020

  • 2mil funding in 2023

  • yc W21 company

Nectar:

  • founded 2021

  • 24mil total raised, series a

Personal Goals
Science
Medicine
Startups
Biotech
Get
Ṁ1,000
to start trading!
Sort by:

related market: https://manifold.markets/sylv/if-i-get-immunotherapy-from-a-start?r=c3lsdg

People are also trading

Will anyone use the compbio platforms ViaScientific or Bigomics for their Regeneron STS project in 2025?
50% chance
Will someone use STEMCELL or bit.bio technology for their regeneron STS project in 2025
52% chance
If I get immunotherapy from a startup, will it turn out to be a good idea?
Which biotech scaleup will have the largest market cap in 2030?
Will we get a cure for cancer before 2028?
4% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
72% chance
Will FDA approve any type of personalized cancer mRNA vaccines before 2028?
50% chance
Will AI developed molecules or drugs be the dominant sources of new biopharma IP by Sep 5 2029?
74% chance
By 2030, will the FDA approve any drug in combination with a checkpoint blockade therapy that substantially reduces immune escape?
54% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
48% chance
© Manifold Markets, Inc.•Terms•Privacy